An explanation of the antiandrogenic properties of 6 -bromo-17 -hydroxy-17 -methyl-4-oxa-5 -androstane-3-one.
D000450:Aldosterone / Q000494:pharmacology; D000726:Androgen Antagonists; D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D001966:Bromine; D002369:Castration; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology; D002474:Cell-Free System; D003345:Corticosterone / Q000494:pharmacology; D003534:Cyproterone / Q000494:pharmacology; D003593:Cytoplasm / Q000187:drug effects; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D007664:Ketosteroids / Q000494:pharmacology; D008297:Male; D010088:Oxidoreductases / Q000378:metabolism; D011467:Prostate / Q000201:enzymology; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D013739:Testosterone / Q000378:metabolism; D014316:Tritium
D000726:Androgen Antagonists; D000731:Androstanes; D007664:Ketosteroids; D014316:Tritium; D013739:Testosterone; D000450:Aldosterone; D003534:Cyproterone; D010088:Oxidoreductases; D012321:DNA-Directed RNA Polymerases; D001966:Bromine; D003345:Corticosterone